Rhythm Pharmaceuticals, Inc.
RYTM· Nasdaq
Released Mar 12, 2018, after the close
10-K filed Mar 12, 2018, 71 days after period end · 0001558370-18-001923
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2017 | Q4 2016 |
|---|---|---|
| Net Income | -$10.53M | -$8.37M |
| EPS Diluted | -$0.41 | -$0.90 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 12, 2018 · 71 d after period end
+13.5% from the close of Mar 7, 2018 to the close of Mar 13, 2018, the first after the release.